National Institute of Mental Health, Klecany, Czech Republic.
Institute of Biophysics and Informatics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
Anticancer Res. 2019 Jul;39(7):3323-3339. doi: 10.21873/anticanres.13475.
The focus of this review is to describe the state-of-art in the development of innovative drug delivery systems for phthalocyanines as photosensitizers for photodynamic therapy (PDT). PDT is a medical treatment combining photosensitizers (PSs) activated by visible light of a specific wavelength to selectively destroy targeted cells, tumor tissues and its surrounding vasculature. In the last decades, PDT has been under intense investigation, first as a promising alternative approach for improved cancer treatment, later against microbial infection and nowadays, mainly in aesthetic medicine, against age-related degeneration. The success of PDT is restricted because of difficulties with administration and skin permeation of PSs. As PDT importance raises, there is high interest for advanced formulations and delivery systems (DDS) for PS, especially formulations based on nanotechnology. Accordingly, this review deals with the innovations pertaining to DDS for PDT as disclosed in recent patents and literature.
本综述的重点是描述酞菁类光动力治疗(PDT)光敏剂创新药物传递系统的最新进展。PDT 是一种将光敏剂(PS)与特定波长的可见光结合使用的医疗方法,可选择性地破坏靶向细胞、肿瘤组织及其周围的脉管系统。在过去的几十年中,PDT 受到了广泛的研究,首先作为一种有前途的癌症治疗方法的替代方法,后来针对微生物感染,如今主要用于美容医学,针对与年龄相关的退行性疾病。由于 PS 的给药和皮肤渗透困难,PDT 的成功受到限制。随着 PDT 的重要性不断提高,人们对 PS 的先进制剂和给药系统(DDS)产生了浓厚的兴趣,尤其是基于纳米技术的制剂。因此,本综述涉及最近专利和文献中披露的 PDT 用 DDS 的创新。